Skip to main content
HSTMHealthStream, Inc.Hold5.2·$33.73
HoldModerate Confidence
Investment thesis

HSTM combines a consistent earnings-beat track record and excellent cash conversion with a rich valuation, elevated leverage, and a negative risk-reward asymmetry now that its price target has effectively been reached.

Thesis pillars

  • Strong Earnings Beat Track Record→Stable
  • Excellent Cash Conversion Quality→Stable
  • Rich Valuation With Limited Upside→Stable
  • +2 more pillars — see the Why tab for full reasoning

Pillars as of Jul 5, 2026, based on the 10-K filed Feb 27, 2026

Full reasoning →

Open full analysis

HealthStream, Inc. (HSTM) Stock Analysis

HoldGrowthQualityModerate Confidence

Healthcare · Health Information Services

Earnings in 4 days (2026-11-02). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Hold if already holding. Not a fresh buy at $33.73, but acceptable to hold if already in. Reasons: Concentration risk — Customer: healthcare industry; Analyst target reached - limited upside remaining.

HealthStream provides SaaS-based workforce development solutions to U.S. healthcare organizations, spanning learning and compliance training, clinical competency development, staff scheduling, and credentialing/privileging through its hStream technology platform. The company,... Read more

$33.73-11.8% A.UpsideScore 5.2/10#15 of 22 Health Information Services
QualityF-score8 / 9FCF yield4.88%
IncomeYield0.40%Payout18.33%sustainable
Stop $31.85Analyst target $29.75(reached)A.R:R -1.0:1
Analyst consensus$35.00+3.8%3 analysts
$33.73price
$35.00mean
$29
$40

Hold if already holding. Not a fresh buy at $33.73, but acceptable to hold if already in. Reasons: Concentration risk — Customer: healthcare industry; Analyst target reached - limited upside remaining. Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Score 5.2/10, moderate confidence.

Passes 2/7 gates (semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and clean insider activity and earnings proximity 4d<=7d. Suitability: aggressive.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-10-29
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Mon, Nov 2, 20264d to earnings· next earnings call

Thesis

Rewards
Sector modifier (Healthcare): +0.5
Strong earnings beat streak (3/4)
Wide economic moat
Risks
Concentration risk — Customer: healthcare industry
Analyst target reached - limited upside remaining
Earnings in 4 days (event risk)

Key Metrics

P/E (TTM)46.8
P/E (Fwd)38.1
Mkt Cap$1.0B
EV/EBITDA20.8
Profit Mgn6.6%
ROE6.0%
Rev Growth12.5%
Beta0.42
Dividend0.40%
Rating analysts11

Quality Signals

Piotroski F8/9MoatWide

Options Flow

IV75%elevated

Concentration Risks(10-K Item 1A)

  • HIGHCustomerhealthcare industry
    10-K Item 1A: 'our lack of market diversification resulting from our concentration on the healthcare industry may make us susceptible to losing market share to our competitors'
  • MEDIUMCustomerhealthcare provider customers
    10-K Item 1: 'We derive a substantial portion of our revenues from a relatively small number of customers that are healthcare providers.'

Material Events(8-K, last 90d)

  • 2026-05-08Item 5.02LOW
    Michael M. Collier was promoted to Chief Operating Officer and EVP from EVP, Corporate Strategy, Development & Operations, effective May 4, 2026, and granted options for 18,781 shares. Routine promotion, not a departure.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker

Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static

Ev Ebitda
0.0
Pe
2.7
Forward Pe
2.9
Analyst Target
3.0
Peg Ratio
3.5
Ps
8.1
Forward P/E: 38.1xPEG: 3.35
GatesMomentum 4.3<4.5A.R:R -1.0=NEGATIVEINSIDER 0.45%=HEAVYEARNINGS PROXIMITY 4d<=7dExecutive change: officer departure/appointmentSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Aggressive
RSI
60 · Neutral
↑ 20D MA↑ 50D MA↑ 200D MAGOLDEN CROSSSupport $29.73Resistance $35.60

Price Targets

A.Upside-11.8%
A.R:R-1.0:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeRisk-Off

Risk Alerts

! Target reached (-11.8% upside)
! momentum at 4.3 (below the engine's 4.5 threshold)
! Negative risk/reward — downside exceeds upside

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-11-02 (4d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is HSTM stock a buy right now?

Hold if already holding. Not a fresh buy at $33.73, but acceptable to hold if already in. Reasons: Concentration risk — Customer: healthcare industry; Analyst target reached - limited upside remaining. Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Analyst target $29.75 reached (−11.8%), stop $31.85 (−5.9%), A.R:R -1.0:1. Score 5.2/10, moderate confidence.

What is the HSTM stock price target?

Analyst target $29.75 reached (−11.8% from $33.73); no take-profit level is published. Analyst target $29.75 reached (−11.8%), stop $31.85 (−5.9%), A.R:R -1.0:1. Stop-loss: $31.85.

What are the risks of investing in HSTM?

Concentration risk — Customer: healthcare industry; Analyst target reached - limited upside remaining; Earnings in 4 days (event risk).

Is HSTM overvalued or undervalued?

HealthStream, Inc. trades at a P/E of 46.8 (forward 38.1). TrendMatrix value score: 3.3/10. Verdict: Hold.

What do analysts say about HSTM?

11 analysts cover HSTM with a consensus score of 3.9/5. Average price target: $35.

What does HealthStream, Inc. do?HealthStream provides SaaS-based workforce development solutions to U.S. healthcare organizations, spanning learning...

HealthStream provides SaaS-based workforce development solutions to U.S. healthcare organizations, spanning learning and compliance training, clinical competency development, staff scheduling, and credentialing/privileging through its hStream technology platform. The company, organized as a single reportable segment since 2023, derives a substantial portion of its subscription-based revenue from a relatively small number of healthcare-provider customers, though no single customer exceeded 10% of 2025 revenue, and has grown through acquisitions including Virsys12 and MissionCare Collective in 2

Related stocks: HNGE (Hinge Health, Inc.) · OMDA (Omada Health, Inc.) · HQY (HealthEquity, Inc.) · PRVA (Privia Health Group, Inc.) · CTEV (Claritev Corporation)
Home › Stocks › HSTM

Latest news

Latest News

TradingKey92d ago
GuruFocus85d ago
MarketBeat85d ago
Tradingkey.com93d ago
GuruFocus100d agoAnalyst
MarketBeat86d ago
TipRanks86d ago
GuruFocus86d ago
GuruFocus86d ago
Dars.gov.et91d ago
TradingKey91d ago
TradingKey91d ago
Yahoo Finance98d agoAnalyst
Moomoo98d agoEarnings
GuruFocus98d ago
MarketBeat88d ago
TradingKey96d ago
Dars.gov.et82d ago
MarketBeat82d ago
MarketBeat94d agoEarnings
Loading more...